ATENOLOL AND CHLORTHALIDONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Atenolol And Chlorthalidone, and when can generic versions of Atenolol And Chlorthalidone launch?
Atenolol And Chlorthalidone is a drug marketed by Aurobindo Pharma Usa, Nostrum Labs, Novitium Pharma, Pliva, Sun Pharm Industries, Twi Pharms, Unichem, Watson Labs, and Zydus Pharms. and is included in nine NDAs.
The generic ingredient in ATENOLOL AND CHLORTHALIDONE is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atenolol And Chlorthalidone
A generic version of ATENOLOL AND CHLORTHALIDONE was approved as atenolol; chlorthalidone by TWI PHARMS on May 31st, 1990.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATENOLOL AND CHLORTHALIDONE?
- What are the global sales for ATENOLOL AND CHLORTHALIDONE?
- What is Average Wholesale Price for ATENOLOL AND CHLORTHALIDONE?
Summary for ATENOLOL AND CHLORTHALIDONE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Clinical Trials: | 4 |
| DailyMed Link: | ATENOLOL AND CHLORTHALIDONE at DailyMed |
Recent Clinical Trials for ATENOLOL AND CHLORTHALIDONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Agenzia Italiana del Farmaco | Phase 4 |
| Federico II University | Phase 4 |
| US Department of Veterans Affairs |
Pharmacology for ATENOLOL AND CHLORTHALIDONE
| Drug Class | Thiazide-like Diuretic beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for ATENOLOL AND CHLORTHALIDONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 074203-001 | Oct 31, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 210028-002 | Mar 8, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pliva | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 074107-001 | Sep 24, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nostrum Labs | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 074404-002 | May 14, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
